“
TL;DR
This proof-of-concept study tested a digital algorithm to guide basal insulin therapy for elderly type 2 diabetes patients at home, finding it was safe and improved glycemic control with reduced variability.
Frontiers in Clinical Diabetes and Healthcare · 13 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This proof-of-concept study tested a digital algorithm to guide basal insulin therapy for elderly type 2 diabetes patients at home, finding it was safe and improved glycemic control with reduced variability.
The study evaluated a digital clinical decision support tool to guide basal insulin adjustments in home healthcare for elderly persons with type 2 diabetes. No severe hypoglycemia (<54 mg/dL) occurred. Seven adverse events were reported, one serious, but none were deemed device-related. The study is limited by its small sample size and partial reporting of methods, suggesting larger studies are needed to confirm efficacy and safety in routine practice.